# FDA Inspection 990271 - Xi'an Libang Pharmaceutical Co Ltd. API Plant - September 22, 2016

Source: https://www.keypedia.com/records/fda_inspections/xian-libang-pharmaceutical-co-ltd-api-plant/1cea5170-cd71-4df1-a2f9-ae4911c9c606
Source feed: FDA_Inspections

> FDA Inspection 990271 for Xi'an Libang Pharmaceutical Co Ltd. API Plant on September 22, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 990271
- Company Name: Xi'an Libang Pharmaceutical Co Ltd. API Plant
- Inspection Date: 2016-09-22
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 883251 - 2014-05-23](https://www.keypedia.com/records/fda_inspections/xian-libang-pharmaceutical-co-ltd-api-plant/ec64e18a-d427-4ec5-9b8e-e37e9e94b0cc)
- [FDA Inspection 726253 - 2011-01-28](https://www.keypedia.com/records/fda_inspections/xian-libang-pharmaceutical-co-ltd-api-plant/1241445a-17d3-4577-8057-8cb320c2b705)
- [FDA Inspection 608014 - 2009-07-30](https://www.keypedia.com/records/fda_inspections/xian-libang-pharmaceutical-co-ltd-api-plant/a7630034-afde-40b4-bf3a-55ffe6a32949)

Company: https://www.keypedia.com/companies/xian-libang-pharmaceutical-co-ltd-api-plant/bb3b5999-890f-4e98-a9a5-da5cc0f169fb

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c